Inclusion Criteria:  Patient with a clinical history of cough. Patients aged ≥12 and ≤70 years inclusive of either sex. The patient will be screened for COVID-19 The patient will be prescribed the study drug following an approved package insert Written informed consent before participation in study-specific procedures  Exclusion Criteria:  Known hypersensitivity to Hydryllin product, the metabolites, or formulation excipients. Covid Patients with moderate and severe condition requires hospitalization or/and associated with the complications. Patients who have a contra-indication (refer to the Syrup Hydryllin prescribing information). Pregnant (assessed on LMP) Breastfeeding women (assessed on interview).